Gilles Alberici
Amministratore Delegato presso Orega Biotech SAS
Provenienza dei contatti di primo grado di Gilles Alberici
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Adienne SA
 Adienne SA Pharmaceuticals: OtherHealth Technology Adienne SA is a biopharmaceutical company engages in the provision of medical development. It focuses on orphan drugs for the treatment of various haematological and immunological diseases. The company was founded on Lugano, Switzerland.
8
| Private Company | Pharmaceuticals: Other | 8 |
Millendo Therapeutics SAS
 Millendo Therapeutics SAS Medical SpecialtiesHealth Technology Millendo Therapeutics SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.
7
| Subsidiary | Medical Specialties | 7 |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
| Subsidiary | Miscellaneous Commercial Services | 6 | |
ORPHELIA Pharma SAS
 ORPHELIA Pharma SAS Pharmaceuticals: MajorHealth Technology ORPHELIA Pharma SA specializes on biopharmaceutical products improving the health and well being of severely disabled children. The company was founded by Hugues Bienaymé in 2007 and is headquartered in Paris, France.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Orega Biotech SAS
 Orega Biotech SAS Medical/Nursing ServicesHealth Services Orega Biotech SAS provides monoclonal antibody-based immunotherapy for cancer patients. It specializes in the discovery of novel targets and the development of first-in-class monoclonal antibodies for the treatment of cancer. The company was founded by Gilles Alberici, Nathalie Bonnefoy, Jean-François Eliaou, and Armand Bensussan in 2010 and is headquartered in Écully, France.
4
| Holding Company | Medical/Nursing Services | 4 |
Octalfa SAS
 Octalfa SAS Investment ManagersFinance Octalfa SAS is a family-owned, independent private equity holding and investment company controlled by Gilles Alberici. Octalfa was established in 2006 and is based near Lyon in Eastern France. The firm manages a portfolio of participations in Life Sciences companies. They are also the key investor of Octalfa 360 Health and Green Technologies, a sector mutual fund invested in listed equity, co-managed by 360 Asset Managers SA and Xénia SARL (aka Xénia Gestion Privée). The fund focuses on sectors such as biotechnology and clean technology. Octalfa is committed to public health issues, and established the Dominique Alberici-Octalfa Corporate Foundation to support initiatives aimed at improving medical and paramedical care for cancer patients and the disabled.
2
| Subsidiary | Investment Managers | 2 |
Jazz Pharmaceuticals II SASU
 Jazz Pharmaceuticals II SASU Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals II SASU engages in the development of biopharmaceutical drugs, proteins and peptides, for the treatment of metabolic diseases and rare diseases. Its lead assets are pegcrisantaspase (Asparec), a PEGylated recombinant L-asparaginase from Erwinia chrysanthemi, and related intellectual property. The company was founded in 2008 and is headquartered in Ecully, France.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Gilles Alberici tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
QIAGEN Beverly LLC
 QIAGEN Beverly LLC BiotechnologyHealth Technology Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| QIAGEN N.V. | Medical Specialties | Chief Executive Officer Director of Finance/CFO General Counsel | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
Intelligent Bio-Systems, Inc.
 Intelligent Bio-Systems, Inc. Medical SpecialtiesHealth Technology Intelligent Bio-Systems is developing a next generation DNA sequencing system that can simultaneously increase the speed and reduce the cost of producing sequence data by a factor of 100 to 1,000. It uses a proprietary chemistry, high-density chip and fluorescent instrument system to accurately decode the sequence of DNA fragments. The technology has the potential to dramatically change the way research is performed and healthcare is delivered. | Medical Specialties | Director/Board Member Director/Board Member | |
| Cellestis International | Director/Board Member Director/Board Member | ||
Cellestis Pty Ltd.
 Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Biotechnology | Director/Board Member Director/Board Member | |
| Qiagen Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member Director/Board Member Director/Board Member | |
Tian Gen Biotech (Beijing) Co. Ltd
 Tian Gen Biotech (Beijing) Co. Ltd Medical DistributorsDistribution Services Part of QIAGEN NV, Tian Gen Biotech (Beijing) Co. Ltd is a Chinese company that engages in the development of nucleic acid preparation products. The company is based in Beijing, China. Tian Gen Biotech (Beijing) Co. was acquired by QIAGEN NV on July 12, 2005 for $0.24 million. | Medical Distributors | Director/Board Member Director/Board Member | |
| Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
QIAGEN Aarhus A/S
 QIAGEN Aarhus A/S Packaged SoftwareTechnology Services QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
QIAGEN Lake Constance GmbH
 QIAGEN Lake Constance GmbH Electronic ComponentsElectronic Technology QIAGEN Lake Constance GmbH develops and produces optical measurement devices for medical, environmental and industrial applications. The company was founded by Thomas Wiest, Klaus Haberstroh, Roland Sackers, Peer Michael Schatz, and Jörg Schickedanz in 1997 and is headquartered in Stockach, Germany. | Electronic Components | Chief Executive Officer Chief Executive Officer | |
Qiagen AG
 Qiagen AG Medical SpecialtiesHealth Technology Qiagen AG manufactures biological products for purification, transfection, and amplification of nucleic acid and proteins. The company was founded on September 15, 1994 and is headquartered in Basel, Switzerland. | Medical Specialties | Director/Board Member Director/Board Member Chairman | |
DxS Ltd.
 DxS Ltd. Medical SpecialtiesHealth Technology DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
QIAGEN Gaithersburg, Inc.
 QIAGEN Gaithersburg, Inc. Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Gaithersburg, Inc. is a company that manufactures and supplies diagnostic devices. The company is based in Gaithersburg, MD. | Medical Specialties | Director/Board Member Director/Board Member | |
Qiagen Hamburg GmbH
 Qiagen Hamburg GmbH Medical/Nursing ServicesHealth Services Part of QIAGEN NV, QIAGEN Hamburg GmbH is a German company that delivers sample to insights solutions, enabling customers to unlock insights from the building blocks of life - DNA, RNA, and proteins. The company is based in Hilden, Germany. The CEOs are Peer Michael Schatz and Roland Sackers. The company was founded in 2013. | Medical/Nursing Services | Chief Executive Officer Chief Executive Officer | |
Qiagen Benelux BV
 Qiagen Benelux BV BiotechnologyHealth Technology Part of QIAGEN NV, QIAGEN Benelux BV provides biotechnology services. The company is based in Venlo, Netherlands. QIAGEN Benelux was founded in 1984. | Biotechnology | Chairman Chairman | |
| Qiagen Taiwan Co. Ltd. | Director/Board Member Director/Board Member | ||
LDN Labor Diagnostika Nord GmbH & Co. KG
 LDN Labor Diagnostika Nord GmbH & Co. KG Pharmaceuticals: OtherHealth Technology LDN Labor Diagnostika Nord GmbH & Co. KG is a German medium-sized company that specializes in the development, production, and marketing of immunoassays for medical laboratories, food analysis, and biomedical research. LDN provides over 200 products in more than 80 countries, serving customers from clinical labs, research facilities, pharmaceutical companies, and the food industry. All of LDN's products are manufactured at its headquarters in Nordhorn, DE. The private company was founded in 1996 and has grown to become a leading player in the market for immunoassays for biogenic amines, with over 35 employees. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Amnisure International LLC
 Amnisure International LLC Electronic Equipment/InstrumentsElectronic Technology Amnisure International LLC manufactures and distributes medical assays in determining the presence of a rupture of fetal membranes in pregnant women. The firm’s technology includes Amnisure ROM test, PAMG-1 Protein, Lateral Flow, Alpha Fetoprotein and Biomarker Testing for PROM and Non-Invasive PROM & pPROM testing. The company was founded in 2005 and is headquartered in Boston, MA. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
QIAGEN Canada, Inc.
 QIAGEN Canada, Inc. Chemicals: SpecialtyProcess Industries Part of Calibre Scientific, Inc., QIAGEN Canada, Inc. is a Canadian company that develops crystallization preparation tools and solutions and related screening technology. The company is based in Toronto, Canada. QIAGEN Canada was acquired by Calibre Scientific, Inc. from QIAGEN NV on January 08, 2020. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| QIAGEN Euro Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member Director/Board Member Director/Board Member | |
| QIAGEN Shenzen Co. Ltd. | Director/Board Member Director/Board Member | ||
| Digene Europe, Inc. | Director/Board Member Director/Board Member | ||
| Qiagen Iberia SL | Director/Board Member Director/Board Member | ||
| QIAGEN Mexico S. de R.L. de C.V. | Director/Board Member Director/Board Member | ||
| Qiagen Servicios Mexico S de RL de CV | Director/Board Member Director/Board Member | ||
| QIAGEN Australia Holding Pty Ltd. | Director/Board Member Director/Board Member | ||
| Corbett Research UK Ltd. | Director/Board Member Director/Board Member | ||
| Corbett Robotics Pty Ltd. | Director/Board Member Director/Board Member | ||
QIAGEN Manchester Ltd.
 QIAGEN Manchester Ltd. Pharmaceuticals: MajorHealth Technology Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The company is based in Manchester, UK. QIAGEN Manchester was founded in 2001. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Qiagen US Finance Holding (Luxembourg) SARL | Director/Board Member Director/Board Member Director/Board Member | ||
| ATQ Biyoteknoloji Iç ve Dis Ticaret Ltd. | Director/Board Member Director/Board Member | ||
| Cellestis (R&D) Pty Ltd. | Director/Board Member Director/Board Member | ||
| QIAGEN India Pvt Ltd. | Director/Board Member Director/Board Member | ||
QIAGEN Sciences LLC
 QIAGEN Sciences LLC Medical SpecialtiesHealth Technology Part of QIAGEN NV, QIAGEN Sciences LLC is a company that manufactures and distributes sample and assay technology products for preanalytical sample preparations. The company is based in Germantown, MD. | Medical Specialties | Director/Board Member Director/Board Member | |
Qiagen Hong Kong Pte Ltd.
 Qiagen Hong Kong Pte Ltd. Medical SpecialtiesHealth Technology Part of QIAGEN NV, Qiagen Hong Kong Pte Ltd. is a company that manufactures and wholesales laboratory equipment. The company is based in Hong Kong, Hong Kong. | Medical Specialties | Director/Board Member Director/Board Member | |
Indical Bioscience GmbH
 Indical Bioscience GmbH Miscellaneous Commercial ServicesCommercial Services INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| N-Dia, Inc. | Director/Board Member Director/Board Member | ||
| Qiagen Business Services Sp zoo | Director/Board Member Director/Board Member | ||
| Qiagen Redwood City, Inc. | Director/Board Member Director/Board Member | ||
Amolyt Pharma SAS
 Amolyt Pharma SAS Pharmaceuticals: MajorHealth Technology Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member Chairman Director/Board Member | |
Qiagen Healthcare Biotechnologies Systems Ltd.
 Qiagen Healthcare Biotechnologies Systems Ltd. Miscellaneous Commercial ServicesCommercial Services Qiagen Healthcare Biotechnologies Systems Ltd. engages in the activities related to maintaining of intangible assets. It involves in the production of products which allow to collect, stabilze and archive DNA and blood related to the forensics life science Business. The company was founded on September 10, 2018 and is headquartered in Manchester, The United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
| Australia | 9 |
| Regno Unito | 7 |
| Germania | 6 |
| Lussemburgo | 4 |
Settori
| Health Technology | 18 |
| Finance | 4 |
| Commercial Services | 4 |
| Health Services | 4 |
| Distribution Services | 3 |
Posizioni
| Director/Board Member | 291 |
| Chairman | 142 |
| Corporate Officer/Principal | 70 |
| Independent Dir/Board Member | 30 |
| Chief Executive Officer | 30 |
Contatti più connessi
| Insiders | |
|---|---|
| Peer Schatz | 83 |
| Roland Sackers | 78 |
| Göran Albert Ando | 44 |
| François Miceli | 43 |
| William W. Crouse | 29 |
| Mounia Chaoui-Roulleau | 27 |
| Bryan Geoffrey Morton | 22 |
| Ian Lobley | 19 |
| Philipp Sixt Lothar von Hugo | 14 |
| Antonio Lanzavecchia | 12 |
| Ezio Ghigo | 11 |
| André de Villers | 11 |
| Aart Jan van der Lely | 10 |
| Guillaume Connan | 10 |
| Simon Peter Ball | 10 |
- Borsa valori
- Insiders
- Gilles Alberici
- Connessioni Società
